Agency Information Collection Activities; Proposed Collection; Comment Request; Biosimilars User Fee Program
Summary

The Food and Drug Administration FDA or Agency is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 PRA Federal Agencies are required to publish notice in the